Laurion Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,201
| Closed | -$219K | – | 293 |
|
|
2025
Q2 | $221K | Buy |
+3,201
| New | +$210K | ﹤0.01% | 332 |
|
|
2024
Q3 | – | Sell |
-12,122
| Closed | -$716K | – | 367 |
|
|
2024
Q2 | $716K | Sell |
12,122
-1,191,910
| -99% | -$74.6M | 0.01% | 325 |
|
|
2024
Q1 | $96M | Buy |
+1,204,032
| New | +$92M | 0.81% | 24 |
|
|
2023
Q2 | – | Sell |
-8,092
| Closed | -$601K | – | 617 |
|
|
2023
Q1 | $601K | Buy |
+8,092
| New | +$679K | ﹤0.01% | 324 |
|
|
2022
Q4 | – | Sell |
-3,600
| Closed | -$347K | – | 443 |
|
|
2022
Q3 | $343K | Sell |
3,600
-7,658
| -68% | -$758K | ﹤0.01% | 417 |
|
|
2022
Q2 | $1.04M | Sell |
11,258
-3,242
| -22% | -$316K | 0.02% | 277 |
|
|
2022
Q1 | $1.47M | Buy |
+14,500
| New | +$1.52M | 0.02% | 230 |
|
|
2021
Q4 | – | Sell |
-12,500
| Closed | -$1.06M | – | 590 |
|
|
2021
Q3 | $1.06M | Buy |
+12,500
| New | +$1.05M | ﹤0.01% | 507 |
|
|
2021
Q2 | – | Sell |
-136,500
| Closed | -$11.2M | – | 760 |
|
|
2021
Q1 | $10.3M | Buy |
136,500
+62,294
| +84% | +$4.54M | 0.06% | 251 |
|
|
2020
Q4 | $5.07M | Buy |
74,206
+23,178
| +45% | +$1.51M | 0.04% | 245 |
|
|
2020
Q3 | $2.98M | Sell |
51,028
-55,293
| -52% | -$3.44M | 0.04% | 269 |
|
|
2020
Q2 | $6.91M | Sell |
106,321
-414,011
| -80% | -$26.1M | 0.08% | 196 |
|
|
2020
Q1 | $30.9M | Buy |
+520,332
| New | +$34.7M | 0.34% | 64 |
|
|
2019
Q2 | – | Sell |
-141,174
| Closed | -$7.6M | – | 944 |
|
|
2019
Q1 | $7.61M | Buy |
141,174
+127,070
| +901% | +$7.84M | 0.1% | 155 |
|
|
2018
Q4 | $924K | Sell |
14,104
-69,285
| -83% | -$5.17M | 0.02% | 575 |
|
|
2018
Q3 | $6.56M | Sell |
83,389
-23,317
| -22% | -$1.67M | 0.06% | 289 |
|
|
2018
Q2 | $6.87M | Buy |
106,706
+2,143
| +2% | +$141K | 0.06% | 289 |
|
|
2018
Q1 | $6.5M | Buy |
104,563
+73,750
| +239% | +$5.29M | 0.05% | 312 |
|
|
2017
Q4 | $2.23M | Sell |
30,813
-201,313
| -87% | -$14.6M | 0.01% | 746 |
|
|
2017
Q3 | $18.9M | Buy |
232,126
+165,426
| +248% | +$13.1M | 0.08% | 193 |
|
|
2017
Q2 | $5.37M | Buy |
+66,700
| New | +$5.27M | 0.03% | 484 |
|
|
2017
Q1 | – | Sell |
-29,720
| Closed | -$2.37M | – | 1343 |
|
|
2016
Q4 | $2.35M | Buy |
29,720
+27,120
| +1,043% | +$2.19M | 0.02% | 538 |
|
|
2016
Q3 | $231K | Buy |
+2,600
| New | +$245K | ﹤0.01% | 763 |
|
|
2015
Q1 | – | Sell |
-3,500
| Closed | -$354K | – | 351 |
|
|
2014
Q4 | $337K | Buy |
+3,500
| New | +$308K | 0.01% | 232 |
|
Other funds holding CVS
Laurion Capital Management's CVS Position: Q3 2025 in Review
Laurion Capital Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 3,201 shares — an estimated $219K sold.
Laurion Capital Management first reported a position in CVS in Q4 2014 and held it in 24 quarters. The position peaked at $96M in Q1 2024. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Laurion Capital Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
- Laurion Capital Management sold 3,201 CVS Health shares in Q3 2025, an estimated $219K.
- Laurion Capital Management first reported a position in CVS Health in Q4 2014 and held it in 24 quarters.
- Laurion Capital Management's CVS Health position peaked at $96M in Q1 2024.
- 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.